A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation

Article

Abstract: Introduction: Oral mucositis (OM) is a significant early complication of hematopoietic cell transpla

Palabras claves:

Hematopoietic cell transplant, low level laser, Mucositis prevention

Autores:

Bensadoun R.J.J., Eduardo C.P., Eduardo F.P., Franquin J.C., Guthrie K.A., Hamdi M., Lloid C.M.E., Marcia Martins Marques, Migliorati C.A., Schubert M.M., Walter N.F.

Fuentes:

scopus